Should I buy or sell Integral Diagnostics stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Integral Diagnostics in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ITGDF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ITGDF, but not buy additional shares or sell existing shares. View ITGDF analyst ratings or view top-rated stocks .

How have ITGDF shares performed in 2024?

Integral Diagnostics' stock was trading at $2.00 at the beginning of the year. Since then, ITGDF stock has decreased by 30.0% and is now trading at $1.40. View the best growth stocks for 2024 here .

How do I buy shares of Integral Diagnostics?

Shares of ITGDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:ITGDF

Integral Diagnostics (ITGDF) Stock Price, News & Analysis

→ Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad)

Free ITGDF Stock Alerts

$1.40

0.00 (0.00%)

(As of 04/26/2024 ET)

Compare

Today's Range: $1.40
▼
$1.40
50-Day Range: $0.96
▼
$1.40
52-Week Range: $0.96
▼
$1.40

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Short Interest

Get Integral Diagnostics alerts:

Ad True Market Insiders

The “Next Bitcoin”? 10 CENT Crypto Set to Explode

The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…

Click For My #1 FREE Crypto for 2024

About Integral Diagnostics

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.

ITGDF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ITGDF Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive ITGDF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integral Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Diagnostics & Research
Sub-Industry: N/A
Current Symbol: OTCMKTS:ITGDF
CUSIP: N/A
CIK: N/A
Web: www.integraldiagnostics.com.au
Phone: 61-3-5339-0704
Fax: N/A
Employees: 2,010
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

Dr. Ian Kadish M.B.A. (Age 61)
MBBCh, CEO, MD & Director
Comp: $606.95k
Dr. Jacqueline Milne MBBS
Executive Director
Mr. Scott Paterson
Chief Financial Officer
Mr. Julian Gully
Chief Information Officer
Ms. Nikki Dalla Valle L.L.B.
General Counsel & Company Secretary
Dr. Lisa Sorger MBBS
Chief Medical Officer

Key Competitors

View All Competitors

ITGDF Stock Analysis - Frequently Asked Questions

Should I buy or sell Integral Diagnostics stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Integral Diagnostics in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ITGDF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ITGDF, but not buy additional shares or sell existing shares.
View ITGDF analyst ratings or view top-rated stocks.
How have ITGDF shares performed in 2024?: Integral Diagnostics' stock was trading at $2.00 at the beginning of the year. Since then, ITGDF stock has decreased by 30.0% and is now trading at $1.40.
View the best growth stocks for 2024 here.
How do I buy shares of Integral Diagnostics?: Shares of ITGDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ITGDF) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial